154 related articles for article (PubMed ID: 24011204)
1. [Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions].
Würtz M; Grove EL
Ugeskr Laeger; 2013 Sep; 175(37):2094-8. PubMed ID: 24011204
[TBL] [Abstract][Full Text] [Related]
2. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.
Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
Am J Gastroenterol; 2010 Dec; 105(12):2533-49. PubMed ID: 21131924
[No Abstract] [Full Text] [Related]
3. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Abraham NS; Hlatky MA; Antman EM; Bhatt DL; Bjorkman DJ; Clark CB; Furberg CD; Johnson DA; Kahi CJ; Laine L; Mahaffey KW; Quigley EM; Scheiman J; Sperling LS; Tomaselli GF;
Circulation; 2010 Dec; 122(24):2619-33. PubMed ID: 21060077
[No Abstract] [Full Text] [Related]
4. [Myocardial infarction: Role of new antiplatelet agents].
Silvain J; Bellemain A; Ecollan P; Montalescot G; Collet JP
Presse Med; 2011 Jun; 40(6):615-24. PubMed ID: 21511430
[TBL] [Abstract][Full Text] [Related]
5. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
Agewall S; Cattaneo M; Collet JP; Andreotti F; Lip GY; Verheugt FW; Huber K; Grove EL; Morais J; Husted S; Wassmann S; Rosano G; Atar D; Pathak A; Kjeldsen K; Storey RF;
Eur Heart J; 2013 Jun; 34(23):1708-13, 1713a-1713b. PubMed ID: 23425521
[No Abstract] [Full Text] [Related]
6. [Antiplatelet therapy in coronary heart disease. Some problems and achivements].
Gratsianskiĭ NA
Kardiologiia; 2010; 50(6):4-21. PubMed ID: 20659022
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs.
Würtz M; Grove EL
Adv Exp Med Biol; 2017; 906():325-350. PubMed ID: 27628008
[TBL] [Abstract][Full Text] [Related]
8. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
[TBL] [Abstract][Full Text] [Related]
9. Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
Alexopoulos D; Goudevenos JA; Xanthopoulou I; Deftereos S; Sitafidis G; Kanakakis I; Hamilos M; Parissis H; Ntalas IV; Angelidis C; Petousis S; Vavuranakis M; Hahalis G; Stefanadis C;
Int J Cardiol; 2013 Oct; 168(6):5329-35. PubMed ID: 23978364
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.
Serebruany VL; Dinicolantonio JJ; Can MM; Pershukov IV; Kuliczkowski W
Cardiology; 2013; 126(1):35-40. PubMed ID: 23860246
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
[TBL] [Abstract][Full Text] [Related]
13. Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.
Clemmensen P; Dridi NP; Holmvang L
Cardiovasc Drugs Ther; 2013 Jun; 27(3):239-45. PubMed ID: 23380983
[TBL] [Abstract][Full Text] [Related]
14. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
Parker WA; Storey RF
Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
[TBL] [Abstract][Full Text] [Related]
15. [Coronary heart disease - what is of importance after coronary intervention?].
Rassaf T; Hamm CW
Dtsch Med Wochenschr; 2011 Feb; 136(5):190-3. PubMed ID: 21271479
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet options for secondary prevention in acute coronary syndromes.
Silvain J; Cayla G; O'Connor SA; Collet JP; Montalescot G
Expert Rev Cardiovasc Ther; 2011 Nov; 9(11):1403-15. PubMed ID: 22059790
[TBL] [Abstract][Full Text] [Related]
17. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
18. [Prominent features of management strategies in acute coronary syndromes with the new oral antiplatelet agents].
Enar R
Turk Kardiyol Dern Ars; 2013 Mar; 41(2):166-71. PubMed ID: 23666308
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effects of aspirin vary with level of P2Y₁₂ receptor blockade supplied by either ticagrelor or prasugrel.
Kirkby NS; Leadbeater PD; Chan MV; Nylander S; Mitchell JA; Warner TD
J Thromb Haemost; 2011 Oct; 9(10):2103-5. PubMed ID: 21812912
[No Abstract] [Full Text] [Related]
20. Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implications.
Fitchett D; Mazer CD; Eikelboom J; Verma S
Can J Cardiol; 2013 Sep; 29(9):1042-7. PubMed ID: 23642333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]